This report contains market size and forecasts of Antihypertensive in global, including the following market information:
Global Antihypertensive Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Antihypertensive Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Antihypertensive companies in 2020 (%)
The global Antihypertensive market was valued at 19810 million in 2020 and is projected to reach US$ 21480 million by 2027, at a CAGR of 2.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihypertensive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihypertensive Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antihypertensive Market Segment Percentages, By Type, 2020 (%)
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors
Global Antihypertensive Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antihypertensive Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Antihypertensive Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antihypertensive Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihypertensive revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Antihypertensive revenues share in global market, 2020 (%)
Key companies Antihypertensive sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Antihypertensive sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antihypertensive Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antihypertensive Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antihypertensive Overall Market Size
2.1 Global Antihypertensive Market Size: 2021 VS 2027
2.2 Global Antihypertensive Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Antihypertensive Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Antihypertensive Players in Global Market
3.2 Top Global Antihypertensive Companies Ranked by Revenue
3.3 Global Antihypertensive Revenue by Companies
3.4 Global Antihypertensive Sales by Companies
3.5 Global Antihypertensive Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antihypertensive Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Antihypertensive Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antihypertensive Players in Global Market
3.8.1 List of Global Tier 1 Antihypertensive Companies
3.8.2 List of Global Tier 2 and Tier 3 Antihypertensive Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antihypertensive Market Size Markets, 2021 & 2027
4.1.2 Diuretics
4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors
4.1.4 Angiotensin Receptor Blockers (ARBs)
4.1.5 Calcium Channel Blockers
4.1.6 Beta Blockers
4.1.7 Alpha Blockers
4.1.8 Vasodilators & Renin Inhibitors
4.2 By Type - Global Antihypertensive Revenue & Forecasts
4.2.1 By Type - Global Antihypertensive Revenue, 2016-2021
4.2.2 By Type - Global Antihypertensive Revenue, 2022-2027
4.2.3 By Type - Global Antihypertensive Revenue Market Share, 2016-2027
4.3 By Type - Global Antihypertensive Sales & Forecasts
4.3.1 By Type - Global Antihypertensive Sales, 2016-2021
4.3.2 By Type - Global Antihypertensive Sales, 2022-2027
4.3.3 By Type - Global Antihypertensive Sales Market Share, 2016-2027
4.4 By Type - Global Antihypertensive Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antihypertensive Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Antihypertensive Revenue & Forecasts
5.2.1 By Application - Global Antihypertensive Revenue, 2016-2021
5.2.2 By Application - Global Antihypertensive Revenue, 2022-2027
5.2.3 By Application - Global Antihypertensive Revenue Market Share, 2016-2027
5.3 By Application - Global Antihypertensive Sales & Forecasts
5.3.1 By Application - Global Antihypertensive Sales, 2016-2021
5.3.2 By Application - Global Antihypertensive Sales, 2022-2027
5.3.3 By Application - Global Antihypertensive Sales Market Share, 2016-2027
5.4 By Application - Global Antihypertensive Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Antihypertensive Market Size, 2021 & 2027
6.2 By Region - Global Antihypertensive Revenue & Forecasts
6.2.1 By Region - Global Antihypertensive Revenue, 2016-2021
6.2.2 By Region - Global Antihypertensive Revenue, 2022-2027
6.2.3 By Region - Global Antihypertensive Revenue Market Share, 2016-2027
6.3 By Region - Global Antihypertensive Sales & Forecasts
6.3.1 By Region - Global Antihypertensive Sales, 2016-2021
6.3.2 By Region - Global Antihypertensive Sales, 2022-2027
6.3.3 By Region - Global Antihypertensive Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Antihypertensive Revenue, 2016-2027
6.4.2 By Country - North America Antihypertensive Sales, 2016-2027
6.4.3 US Antihypertensive Market Size, 2016-2027
6.4.4 Canada Antihypertensive Market Size, 2016-2027
6.4.5 Mexico Antihypertensive Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Antihypertensive Revenue, 2016-2027
6.5.2 By Country - Europe Antihypertensive Sales, 2016-2027
6.5.3 Germany Antihypertensive Market Size, 2016-2027
6.5.4 France Antihypertensive Market Size, 2016-2027
6.5.5 U.K. Antihypertensive Market Size, 2016-2027
6.5.6 Italy Antihypertensive Market Size, 2016-2027
6.5.7 Russia Antihypertensive Market Size, 2016-2027
6.5.8 Nordic Countries Antihypertensive Market Size, 2016-2027
6.5.9 Benelux Antihypertensive Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Antihypertensive Revenue, 2016-2027
6.6.2 By Region - Asia Antihypertensive Sales, 2016-2027
6.6.3 China Antihypertensive Market Size, 2016-2027
6.6.4 Japan Antihypertensive Market Size, 2016-2027
6.6.5 South Korea Antihypertensive Market Size, 2016-2027
6.6.6 Southeast Asia Antihypertensive Market Size, 2016-2027
6.6.7 India Antihypertensive Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Antihypertensive Revenue, 2016-2027
6.7.2 By Country - South America Antihypertensive Sales, 2016-2027
6.7.3 Brazil Antihypertensive Market Size, 2016-2027
6.7.4 Argentina Antihypertensive Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antihypertensive Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Antihypertensive Sales, 2016-2027
6.8.3 Turkey Antihypertensive Market Size, 2016-2027
6.8.4 Israel Antihypertensive Market Size, 2016-2027
6.8.5 Saudi Arabia Antihypertensive Market Size, 2016-2027
6.8.6 UAE Antihypertensive Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antihypertensive Major Product Offerings
7.1.4 Pfizer Antihypertensive Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Norvatis
7.2.1 Norvatis Corporate Summary
7.2.2 Norvatis Business Overview
7.2.3 Norvatis Antihypertensive Major Product Offerings
7.2.4 Norvatis Antihypertensive Sales and Revenue in Global (2016-2021)
7.2.5 Norvatis Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Antihypertensive Major Product Offerings
7.3.4 Merck & Co. Antihypertensive Sales and Revenue in Global (2016-2021)
7.3.5 Merck & Co. Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Antihypertensive Major Product Offerings
7.4.4 Sanofi Antihypertensive Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Antihypertensive Major Product Offerings
7.5.4 AstraZeneca Antihypertensive Sales and Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 GSK
7.6.1 GSK Corporate Summary
7.6.2 GSK Business Overview
7.6.3 GSK Antihypertensive Major Product Offerings
7.6.4 GSK Antihypertensive Sales and Revenue in Global (2016-2021)
7.6.5 GSK Key News
7.7 Daiichi-Sankyo
7.7.1 Daiichi-Sankyo Corporate Summary
7.7.2 Daiichi-Sankyo Business Overview
7.7.3 Daiichi-Sankyo Antihypertensive Major Product Offerings
7.4.4 Daiichi-Sankyo Antihypertensive Sales and Revenue in Global (2016-2021)
7.7.5 Daiichi-Sankyo Key News
7.8 Boehringer-Ingelheim
7.8.1 Boehringer-Ingelheim Corporate Summary
7.8.2 Boehringer-Ingelheim Business Overview
7.8.3 Boehringer-Ingelheim Antihypertensive Major Product Offerings
7.8.4 Boehringer-Ingelheim Antihypertensive Sales and Revenue in Global (2016-2021)
7.8.5 Boehringer-Ingelheim Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antihypertensive Major Product Offerings
7.9.4 Bayer Antihypertensive Sales and Revenue in Global (2016-2021)
7.9.5 Bayer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Antihypertensive Major Product Offerings
7.10.4 Johnson & Johnson Antihypertensive Sales and Revenue in Global (2016-2021)
7.10.5 Johnson & Johnson Key News
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Corporate Summary
7.11.2 Bristol-Myers Squibb Antihypertensive Business Overview
7.11.3 Bristol-Myers Squibb Antihypertensive Major Product Offerings
7.11.4 Bristol-Myers Squibb Antihypertensive Sales and Revenue in Global (2016-2021)
7.11.5 Bristol-Myers Squibb Key News
7.12 Tekeda
7.12.1 Tekeda Corporate Summary
7.12.2 Tekeda Antihypertensive Business Overview
7.12.3 Tekeda Antihypertensive Major Product Offerings
7.12.4 Tekeda Antihypertensive Sales and Revenue in Global (2016-2021)
7.12.5 Tekeda Key News
7.13 Ranbaxy Laboratories
7.13.1 Ranbaxy Laboratories Corporate Summary
7.13.2 Ranbaxy Laboratories Antihypertensive Business Overview
7.13.3 Ranbaxy Laboratories Antihypertensive Major Product Offerings
7.13.4 Ranbaxy Laboratories Antihypertensive Sales and Revenue in Global (2016-2021)
7.13.5 Ranbaxy Laboratories Key News
7.14 Shihuida Pharm
7.14.1 Shihuida Pharm Corporate Summary
7.14.2 Shihuida Pharm Business Overview
7.14.3 Shihuida Pharm Antihypertensive Major Product Offerings
7.14.4 Shihuida Pharm Antihypertensive Sales and Revenue in Global (2016-2021)
7.14.5 Shihuida Pharm Key News
7.15 Second Pharmaceutical
7.15.1 Second Pharmaceutical Corporate Summary
7.15.2 Second Pharmaceutical Business Overview
7.15.3 Second Pharmaceutical Antihypertensive Major Product Offerings
7.15.4 Second Pharmaceutical Antihypertensive Sales and Revenue in Global (2016-2021)
7.15.5 Second Pharmaceutical Key News
7.16 Lupin Limited.
7.16.1 Lupin Limited. Corporate Summary
7.16.2 Lupin Limited. Business Overview
7.16.3 Lupin Limited. Antihypertensive Major Product Offerings
7.16.4 Lupin Limited. Antihypertensive Sales and Revenue in Global (2016-2021)
7.16.5 Lupin Limited. Key News
7.17 Yangtze River Pharmaceutical
7.17.1 Yangtze River Pharmaceutical Corporate Summary
7.17.2 Yangtze River Pharmaceutical Business Overview
7.17.3 Yangtze River Pharmaceutical Antihypertensive Major Product Offerings
7.17.4 Yangtze River Pharmaceutical Antihypertensive Sales and Revenue in Global (2016-2021)
7.17.5 Yangtze River Pharmaceutical Key News
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Corporate Summary
7.18.2 Hengrui Medicine Business Overview
7.18.3 Hengrui Medicine Antihypertensive Major Product Offerings
7.18.4 Hengrui Medicine Antihypertensive Sales and Revenue in Global (2016-2021)
7.18.5 Hengrui Medicine Key News
7.19 Qilu Pharmaceutical
7.19.1 Qilu Pharmaceutical Corporate Summary
7.19.2 Qilu Pharmaceutical Business Overview
7.19.3 Qilu Pharmaceutical Antihypertensive Major Product Offerings
7.19.4 Qilu Pharmaceutical Antihypertensive Sales and Revenue in Global (2016-2021)
7.19.5 Qilu Pharmaceutical Key News
7.20 HUALON
7.20.1 HUALON Corporate Summary
7.20.2 HUALON Business Overview
7.20.3 HUALON Antihypertensive Major Product Offerings
7.20.4 HUALON Antihypertensive Sales and Revenue in Global (2016-2021)
7.20.5 HUALON Key News
7.21 Dawnrays
7.21.1 Dawnrays Corporate Summary
7.21.2 Dawnrays Business Overview
7.21.3 Dawnrays Antihypertensive Major Product Offerings
7.21.4 Dawnrays Antihypertensive Sales and Revenue in Global (2016-2021)
7.21.5 Dawnrays Key News
7.22 HISUN Pharmceutical
7.22.1 HISUN Pharmceutical Corporate Summary
7.22.2 HISUN Pharmceutical Business Overview
7.22.3 HISUN Pharmceutical Antihypertensive Major Product Offerings
7.22.4 HISUN Pharmceutical Antihypertensive Sales and Revenue in Global (2016-2021)
7.22.5 HISUN Pharmceutical Key News
8 Global Antihypertensive Production Capacity, Analysis
8.1 Global Antihypertensive Production Capacity, 2016-2027
8.2 Antihypertensive Production Capacity of Key Manufacturers in Global Market
8.3 Global Antihypertensive Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antihypertensive Supply Chain Analysis
10.1 Antihypertensive Industry Value Chain
10.2 Antihypertensive Upstream Market
10.3 Antihypertensive Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antihypertensive Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Antihypertensive in Global Market
Table 2. Top Antihypertensive Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Antihypertensive Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Antihypertensive Revenue Share by Companies, 2016-2021
Table 5. Global Antihypertensive Sales by Companies, (K Units), 2016-2021
Table 6. Global Antihypertensive Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antihypertensive Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Antihypertensive Product Type
Table 9. List of Global Tier 1 Antihypertensive Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antihypertensive Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type